These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
63 related articles for article (PubMed ID: 22204093)
1. Complications of monoclonal antibody therapy. Meisel K; Rizvi S Med Health R I; 2011 Nov; 94(11):317-9. PubMed ID: 22204093 [No Abstract] [Full Text] [Related]
2. [Monoclonal antibodies and chemotherapy: planning and management of symptoms]. Berardini R Suppl Tumori; 2004; 3(4):S130-2. PubMed ID: 15206239 [No Abstract] [Full Text] [Related]
3. Interstitial pneumonitis related to rituximab therapy. Burton C; Kaczmarski R; Jan-Mohamed R N Engl J Med; 2003 Jun; 348(26):2690-1; discussion 2690-1. PubMed ID: 12826649 [No Abstract] [Full Text] [Related]
4. Interstitial pneumonitis following rituximab therapy for immune thrombocytopenic purpura (ITP). Swords R; Power D; Fay M; O'Donnell R; Murphy PT Am J Hematol; 2004 Sep; 77(1):103-4. PubMed ID: 15307117 [No Abstract] [Full Text] [Related]
5. Severe interstitial pneumonitis associated with infliximab therapy. Chatterjee S Scand J Rheumatol; 2004; 33(4):276-7. PubMed ID: 15370726 [No Abstract] [Full Text] [Related]
6. [Rituximab. A monoclonal CD20 antibody--hematological indications and possible treatments for immunoinflammatory diseases]. Hansen PB; Hasselbalch HC Ugeskr Laeger; 2004 Feb; 166(6):466-9. PubMed ID: 15045710 [No Abstract] [Full Text] [Related]
10. Interstitial pneumonitis and alveolar hemorrhage complicating use of rituximab: case report and review of the literature. Heresi GA; Farver CF; Stoller JK Respiration; 2008; 76(4):449-53. PubMed ID: 17596682 [TBL] [Abstract][Full Text] [Related]